참고문헌
- Alberg A, Ford J, Samet J (2007). Epidemiology of lung cancer. ACCP evidence-based clinical practice guidelines (2nd ed), 132(3 Suppl), 29-55. https://doi.org/10.1378/chest.07-1347
- Au J, Mang O, Foo W, et al (2004). Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000. Lung Cancer, 45, 143-52. https://doi.org/10.1016/j.lungcan.2004.01.012
- Babaei M, Jaafarzadeh H, Sadjadi A, et al (2009). Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006. Iranian J Publ Health, 38, 35-45.
- Bosetti C, Bertuccio P, Levi F, et al (2008). Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol, 19, 631-40.
- Chan-Yeung M, Koo L, Ho J, et al (2003). Risk factors associated with lung cancer in Hong Kong. Lung Cancer, 40, 131-40. https://doi.org/10.1016/S0169-5002(03)00036-9
- Cruz CD, Tanoue L, Matthay R (2011). Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med, 32, 605-44. https://doi.org/10.1016/j.ccm.2011.09.001
- Du YX, Cha Q, Chen XW, et al (1996). An epidemiological study of risk factors for lung cancer in Guangzhou, China. Lung Cancer, 14, 9-37. https://doi.org/10.1016/S0169-5002(96)90208-1
- Fauci, Anthony S (2008). Harrison's principles of internal medicine, McGraw-Hill Medical New York.
- Ferlay J, Shin H, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Ferlay J, Shin H, Bray F, et al (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide, Lyon, France, IARC cancerbase no. 10.
- Goya MM (2007). Iranian annual cancer registration report 2003/2008, tehran, ministry of health and medical education, health deputy. Center for Disease Control and Prevention.
- Hadoux J, Besse B, Planchard D (2011). Lung cancer in never smoker: Epidemiology, molecular profiles and treatment. Presse Med, 40, 371-8. https://doi.org/10.1016/j.lpm.2011.02.001
- Horner M, Ries L, Krapcho M (2009). SEER Cancer [Online]. Bethesda, MD: Based on November 2008 SEER submission data, posted to the SEER website.
- Hosseini M, Naghan P, Karimi S, et al ( (2009). Environmental risk factors for lung cancer in Iran: a case-control study. Int J Epidemiol, 38, 989-96. https://doi.org/10.1093/ije/dyp218
- Hshyany AA, Farahmand M, Hasanzadeh J, et al (2012). The incidence of lung cancer in the province based on cancer registry data 2001-8. Payesh, 11, 483 - 77.
- Hu Z, Wu C, Shi Y, et al (2011). A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet, 43, 792-6. https://doi.org/10.1038/ng.875
- Hussain S, Hofseth L, Harris C (2001). Tumor suppressor genes:at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer, 34, 7-15. https://doi.org/10.1016/S0169-5002(01)00370-1
- Janssen-Heijnen M, Coebergh J (2003). The changing epidemiology of lung cancer in Europe. Lung Cancer, 41, 245-58. https://doi.org/10.1016/S0169-5002(03)00230-7
- Jemal A, Bray F, Center M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jiao Z, Hai-Tao W, Bao-Guo L (2014). Prognostic Significance of Circulating Tumor Cells in Small-Cell Lung Cancer Patients:a Meta-analysis. Asian Pac J Cancer Prev, 15, 8429-33. https://doi.org/10.7314/APJCP.2014.15.19.8429
- Kabat G (1996). Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States. Lung Cancer 15, 1-20. https://doi.org/10.1016/0169-5002(95)00566-8
- Kazemi-Lomedasht F, Rami A, Zarghami N (2013). Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull, 3, 127-30.
- Keyghobadi N, Rafiemanesh H, Hafshejani AM, et al (2015). Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran. Asian Pac J Cancer Prev, 16, 1409-13. https://doi.org/10.7314/APJCP.2015.16.4.1409
- Khajehkazemi R, Sadeghirad B, Karamouzian M (2013). The projection of burden of disease in Islamic Republic of Iran to 2025. PloS ONE, 8, 76881. https://doi.org/10.1371/journal.pone.0076881
- Koohi F, Enayatrad M, Salehiniya H (2015). A Study of the Epidemiology and Trends in Cancer Incidence in Iranian Elderly 2003-2009. Arak Med University J, 18, 57-66.
- Koosha A, Farahbakhsh M, Hakimi S, et al (2011). Epidemiology of Cancer in East Azerbaijan province in 2008. Tabriz University Med Sci, 32, 74-9.
- Li Y, Sheu C, Ye Y, et al (2010). Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol, 11, 321-30. https://doi.org/10.1016/S1470-2045(10)70042-5
- Mehrabani D, Tabei S, Heydari S, et al (2008). Cancer Occurrence in Fars Province, Southern Iran. Iranian Red Crescent Med J, 10, 314-22.
- Miki D, Kubo M, Takahashi A, et al (2010). Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet, 42, 893-6. https://doi.org/10.1038/ng.667
- Ming Z, Cui-Huan W, Xiao-Ling Z, et al (2014). Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central china region. Asian Pac J Cancer Prev, 15, 7799-803. https://doi.org/10.7314/APJCP.2014.15.18.7799
- Molina J, Yang P, Cassivi S, et al (2008). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 83, 584-94. https://doi.org/10.1016/S0025-6196(11)60735-0
- Organization WH (2011). WHO report on the global tobacco epidemic, 2011, warning about the dangers of tobacco. , Geneva, Switzerland, WHO press, 2011.
- Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Sadjadi A, Malekzadeh R, Derakhshan M, et al (2003). Cancer occurrence in Ardabil: Results of a population based Cancer Registry from Iran. Int J Cancer, 107, 113-8. https://doi.org/10.1002/ijc.11359
- Seyed Mohsen Mousavi, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
- Shiraishi K, Kunitoh H, Daigo Y, et al (2012). A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet, 44, 900-3. https://doi.org/10.1038/ng.2353
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Somi M, Farhang S, Mirinezhad S, et al ( 2008). Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 9(2), 327-30.
- Toh C-K ( 2009). The changing epidemiology of lung cancer. Methods Mol Biol, 472, 397-411. https://doi.org/10.1007/978-1-60327-492-0_19
- Toh C, Lim W (2007). Lung cancer in never-smokers. J Clin Pathol, 60, 337-40.
- Wahbah M, Boroumand N, Castro C, et al (2007). Changing trends in the distribution of the histologic types of lung cancer: a review of 4439 cases. Ann Diagn Pathol, 11, 89-96. https://doi.org/10.1016/j.anndiagpath.2006.04.006
- Wang SY, Hu Yl, Wu Yl, et al (1996). A comparative study of the risk factors for lung cancer in Guangdong, China. Lung Cancer, 14, 99-105. https://doi.org/10.1016/0169-5002(95)00515-3
- Wang Y, Broderick P, Webb E, et al (2008). Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet, 40, 1407-9. https://doi.org/10.1038/ng.273
피인용 문헌
- Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention vol.63, pp.7, 2018, https://doi.org/10.1038/s10038-018-0450-y